ISS
UTHR icon

Intesa Sanpaolo SpA.’s United Therapeutics UTHR Stock Holding History

Intesa Sanpaolo SpA.’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.29M Buy
2,380
+61
+3% +$34.4K 0.04% 119
2026
Q1 		$1.35M Sell
2,319
-990
-30% -$493K 0.08% 103
2025
Q4 		$1.64M Buy
+3,309
New +$1.54M 0.09% 103

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Intesa Sanpaolo SpA.'s UTHR Position: Q2 2026 in Review

Intesa Sanpaolo SpA. increased its United Therapeutics (UTHR) stake by 2.6% in Q2 2026, buying an estimated $34.4K and bringing the position to 2,380 shares worth $1.29M. The position accounts for 0.04% of the portfolio, ranked #119.

Intesa Sanpaolo SpA. first reported a position in UTHR in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.64M in Q4 2025. 875 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Intesa Sanpaolo SpA. held 2,380 shares of United Therapeutics worth $1.29M as of Q2 2026.
  • Intesa Sanpaolo SpA. bought 61 United Therapeutics shares in Q2 2026, an estimated $34.4K.
  • United Therapeutics made up 0.04% of Intesa Sanpaolo SpA.'s portfolio in Q2 2026, its #119 holding.
  • Intesa Sanpaolo SpA. first reported a position in United Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • Intesa Sanpaolo SpA.'s United Therapeutics position peaked at $1.64M in Q4 2025.
  • 875 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Intesa Sanpaolo SpA.'s 13F filing for Q2 2026, filed 31 Jul 2026.